Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
FDA approves fruquintinib for refractory metastatic colorectal cancerNov 6Regulatory decisionfruquintinib
Merck collaborator posts pancreatic cancer results; new MK-1045, COPD trial records surfaceNov 6Weekly roundup, 14 itemsDaiichi SankyoensifentrineUpdated
Cardiff Oncology posts results for terminated onvansertib pancreatic cancer trialNov 4Trial updateCardiff Oncology
Johns Hopkins-sponsored HCC trial of Nivolumab plus Relatlimab posts results, now not recruitingOct 29Weekly roundup, 2 itemsBristol Myers Squibbnavlimetostat
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Pfizer registers real-world observational study of marstacimab in hemophilia A and B patientsOct 9Weekly roundup, 8 itemsabrocitinibcyclophosphamide
Oncolytics reports faster enrollment in REO 033 colorectal cancer studyOct 1Trial updateCoherus Oncology, Inc.Oncolytics BiotechUpdated
Cypherpunk's Leap Therapeutics subsidiary aligns with FDA on Phase 3 trial for sirexatamabAug 12Quarterly updateCypherpunk Technologies Inc.
XBiotech posts results for XB2001 pancreatic cancer trial, over five years after registrationAug 4Trial updateXB2001XBiotech, Inc.